Submission Details
| 510(k) Number | K162918 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 18, 2016 |
| Decision Date | February 09, 2017 |
| Days to Decision | 114 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K162918 is an FDA 510(k) clearance for the Atlas Spine Expandable Interbody System, a Intervertebral Fusion Device With Bone Graft, Lumbar (Class II — Special Controls, product code MAX), submitted by Atlas Spine, Inc. (Jupiter, US). The FDA issued a Cleared decision on February 9, 2017, 114 days after receiving the submission on October 18, 2016. This device falls under the Orthopedic review panel. Regulated under 21 CFR 888.3080.
| 510(k) Number | K162918 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 18, 2016 |
| Decision Date | February 09, 2017 |
| Days to Decision | 114 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | MAX — Intervertebral Fusion Device With Bone Graft, Lumbar |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 888.3080 |
| Definition | Intended To Stabilize Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft. |